Giessener Elektronische Bibliothek

GEB - Giessener Elektronische Bibliothek

Update on the types and usage of liquid biopsies in the clinical setting: a systematic review

Arneth, Borros


Originalveröffentlichung: (2018) BMC Cancer 18(1):527 doi: 10.1186/s12885-018-4433-3
Zum Volltext im pdf-Format: Dokument 1.pdf (865 KB)


Bitte beziehen Sie sich beim Zitieren dieses Dokumentes immer auf folgende
URN: urn:nbn:de:hebis:26-opus-152445
URL: http://geb.uni-giessen.de/geb/volltexte/2020/15244/

Bookmark bei del.icio.us


Freie Schlagwörter (Englisch): liquid biopsy , biomarker , tumor marker , cancer diagnostics
Sammlung: Open Access - Publikationsfonds
Universität Justus-Liebig-Universit√§t Gie√üen
Institut: Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics
Fachgebiet: Medizin
DDC-Sachgruppe: Medizin
Dokumentart: Aufsatz
Sprache: Englisch
Erstellungsjahr: 2018
Publikationsdatum: 01.07.2020
Kurzfassung auf Englisch: BACKGROUND: This systematic review aimed to gather evidence from research on the current state of liquid biopsy in medical practice, specifically focusing on mutation detection and monitoring.
METHODS: A systematic search was performed via Medline.
RESULTS: The results of this investigation indicate that liquid biopsy plays a critical role in the detection and management of tumors. This technique gives healthcare providers the ability to gather critical and reliable information that may potentially shape the diagnosis, treatment, and prognosis of a variety of cancers in the near future. This study further reveals that liquid biopsy has several potential shortcomings that may limit its application and use in the healthcare setting. Nevertheless, liquid biopsy remains a valuable tool that is gradually becoming a part of routine healthcare practice in oncology departments and hospitals worldwide.
CONCLUSIONS: The evidence described herein reveals the potential relevance of liquid biopsy as an important prognostic, diagnostic, and theranostic tool. This non-invasive procedure enables healthcare practitioners to detect and monitor genomic alterations and will likely replace tumor tissue biopsy as the standard method for detecting and monitoring mutations in the future. The information obtained herein can enable physicians to make informed decisions regarding current treatment options; however, liquid biopsy has not yet been incorporated into routine clinical diagnostics for cancer patients.
Lizenz: Lizenz-Logo  Creative Commons - Namensnennung 4.0